Company Filing History:
Years Active: 2016
Title: The Innovations of Catherine Massacrier
Introduction
Catherine Massacrier is a notable inventor based in Tassin la Demi Lune, France. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents.
Latest Patents
Catherine holds a patent for TLR3 binding agents. This invention relates to antibodies, including monoclonal antibodies, antibody fragments, and derivatives that specifically bind TLR3. These agents can modulate signaling, potentially inhibiting it. The patent also encompasses methods for producing such antibodies, as well as pharmaceutical compositions that include them. The applications of her invention extend to diagnosing, treating, or preventing diseases, particularly autoimmune and inflammatory diseases.
Career Highlights
Catherine is currently associated with Innate Pharma, a company focused on developing innovative immunotherapies. Her work has been instrumental in advancing the understanding of immune responses and therapeutic interventions.
Collaborations
Catherine collaborates with esteemed colleagues, including Laurent Gauthier and Yannis Morel. Their combined expertise contributes to the innovative research and development at Innate Pharma.
Conclusion
Catherine Massacrier's contributions to biotechnology and her patent on TLR3 binding agents highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical treatments.